Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-217622 drug-drug interaction study in healthy adults
jRCT2031210595Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ensitrelvir in coronavirus disease 2019 (COVID-19), sponsored by Shionogi & Co., Ltd. Primary endpoints: Digoxin pharmacokinetics, Rosuvastatin pharmacokinetics and 3 more. Started Feb 2022; status: completed.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2031210595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210595.